Table 2: Pearson's correlations between dosages of plasmatic fatty acids and BES, in the placebo group, before (1) and after (2) treatment.
| BES (1) | BES (2) | DHA (1) | DHA (2) | EPA (1) | EPA (2) | |
| BES (1) | 1.00 | -0.14 | -0.54 | 0.05 | -0.38 | 0.25 |
| BES (2) | -0.14 | 1.00 | 0.22 | 0.02 | 0.25 | 0.25 |
| DHA (1) | -0.54* | 0.22 | 1.00 | 0.46 | 0.04 | -0.33 |
| DHA (2) | 0.05 | 0.02 | 0.46 | 1.00 | -0.21 | -0.22 |
| EPA (1) | -0.38 | 0.25 | 0.04 | -0.21 | 1.00 | 0.08 |
| EPA (2) | 0.25 | 0.26 | -0.33 | -0.22 | 0.08 | 1.00 |
*Correlations considered moderate to strong